These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 35857212)

  • 1. Role of stereotactic body radiotherapy in multidisciplinary management of liver metastases in patients with colorectal cancer.
    Sanuki N; Takeda A; Tsurugai Y; Eriguchi T
    Jpn J Radiol; 2022 Oct; 40(10):1009-1016. PubMed ID: 35857212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recursive partitioning model-based analysis for survival of colorectal cancer patients with lung and liver oligometastases treated with stereotactic body radiation therapy.
    Franzese C; Comito T; Franceschini D; Loi M; Clerici E; Navarria P; De Rose F; Di Brina L; Mancosu P; Reggiori G; Tomatis S; Scorsetti M
    J Cancer Res Clin Oncol; 2020 May; 146(5):1227-1234. PubMed ID: 32056005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Contemporary Update on the Role of Stereotactic Body Radiation Therapy (SBRT) for Liver Metastases in the Evolving Landscape of Oligometastatic Disease Management.
    Robin TP; Raben D; Schefter TE
    Semin Radiat Oncol; 2018 Oct; 28(4):288-294. PubMed ID: 30309639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of stereotactic body radiotherapy for oligometastasis from colorectal cancer.
    Takeda A; Sanuki N; Kunieda E
    World J Gastroenterol; 2014 Apr; 20(15):4220-9. PubMed ID: 24764660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of Stereotactic Body Radiation Therapy for patient with unresectable liver metastases from colorectal cancer.
    Py JF; Salleron J; Courrech F; Beckendorf V; Croisé-Laurent V; Peiffert D; Vogin G; Dietmann AS
    Cancer Radiother; 2021 Jun; 25(4):350-357. PubMed ID: 33618909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
    Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
    Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of stereotactic body radiation therapy in the treatment of liver metastases: clinical results and prognostic factors.
    Clerici E; Comito T; Franzese C; Di Brina L; Tozzi A; Iftode C; Navarria P; Mancosu P; Reggiori G; Tomatis S; Scorsetti M
    Strahlenther Onkol; 2020 Apr; 196(4):325-333. PubMed ID: 31605163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local Control Outcomes Using Stereotactic Body Radiation Therapy for Liver Metastases From Colorectal Cancer.
    Joo JH; Park JH; Kim JC; Yu CS; Lim SB; Park IJ; Kim TW; Hong YS; Kim KP; Yoon SM; Park J; Kim JH
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):876-883. PubMed ID: 29063852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic body radiotherapy for colorectal cancer liver metastases: A systematic review.
    Petrelli F; Comito T; Barni S; Pancera G; Scorsetti M; Ghidini A;
    Radiother Oncol; 2018 Dec; 129(3):427-434. PubMed ID: 29997034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic body radiation therapy for colorectal cancer liver metastases.
    Lukovic J; Dawson LA
    J Gastrointest Oncol; 2024 Aug; 15(4):1917-1925. PubMed ID: 39279927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic body radiation therapy for colorectal cancer liver metastases; early results.
    Burkon P; Slampa P; Kazda T; Slavik M; Prochazka T; Vrzal M
    Klin Onkol; 2012; 25 Suppl 2():2S93-7. PubMed ID: 23581024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of extra-cranial stereotactic body radiotherapy for metastatic colorectal cancer: Dose and site of metastases matter.
    Thompson R; Cheung P; Chu W; Myrehaug S; Poon I; Sahgal A; Soliman H; Tseng CL; Wong S; Ung Y; Beatriz Kinupe Abrahão A; Erler D; Zhang L; Ko YJ; Chung HT
    Radiother Oncol; 2020 Jan; 142():236-245. PubMed ID: 31543287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiation therapy for colorectal liver metastases.
    Mohamad I; Barry A; Dawson L; Hosni A
    Int J Hyperthermia; 2022; 39(1):611-619. PubMed ID: 35465818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases.
    Klement RJ; Abbasi-Senger N; Adebahr S; Alheid H; Allgaeuer M; Becker G; Blanck O; Boda-Heggemann J; Brunner T; Duma M; Eble MJ; Ernst I; Gerum S; Habermehl D; Hass P; Henkenberens C; Hildebrandt G; Imhoff D; Kahl H; Klass ND; Krempien R; Lewitzki V; Lohaus F; Ostheimer C; Papachristofilou A; Petersen C; Rieber J; Schneider T; Schrade E; Semrau R; Wachter S; Wittig A; Guckenberger M; Andratschke N
    BMC Cancer; 2019 Feb; 19(1):173. PubMed ID: 30808323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Stereotactic Body Radiation Therapy in the Management of Liver Metastases.
    Lee SL; Bassetti MF; Rusthoven CG
    Semin Radiat Oncol; 2023 Apr; 33(2):181-192. PubMed ID: 36990635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence.
    Nakamura M; Hashimoto N; Mayahara H; Uezono H; Harada A; Nishikawa R; Matsuo Y; Kawaguchi H; Nishimura H
    Radiat Oncol; 2018 Apr; 13(1):75. PubMed ID: 29688858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic body radiotherapy for oligo-recurrence within the nodal area from colorectal cancer.
    Seo YS; Kim MS; Yoo HJ; Jang WI
    World J Gastroenterol; 2014 Feb; 20(8):2005-13. PubMed ID: 24587675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Local ablative radiotherapy of oligometastatic colorectal cancer].
    Petersen C; Gauer T
    Radiologe; 2017 Feb; 57(2):105-110. PubMed ID: 28054139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world effectiveness and safety of stereotactic body radiotherapy for liver metastases with different respiratory motion management techniques.
    Hernando-Requejo O; Chen X; López M; Sánchez E; García J; García P; Alonso R; Montero A; Ciervide R; Álvarez B; Zucca D; García Aranda M; Valero J; Fernández Letón P; Rubio C
    Strahlenther Onkol; 2023 Nov; 199(11):1000-1010. PubMed ID: 37728734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors for survival of oligometastatic colorectal cancer treated with Stereotactic body radiation therapy.
    Franzese C; Comito T; Toska E; Tozzi A; Clerici E; De Rose F; Franceschini D; Navarria P; Reggiori G; Tomatis S; Scorsetti M
    Radiother Oncol; 2019 Apr; 133():220-226. PubMed ID: 30414754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.